Plecanatide
Brand name: Trulance
Rank #367 of 500 drugs by total cost
$26.6M
Total Cost
36,026
Total Claims
$26.6M
Total Cost
1,661
Prescribers
$738
Cost per Claim
3,100
Beneficiaries
47,453
30-Day Fills
$16K
Avg Cost/Provider
22
Avg Claims/Provider
About Plecanatide
Plecanatide (sold as Trulance) was prescribed 36,026 times by 1,661 Medicare Part D providers in 2023, costing the program $26.6M. At $738 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 364 | Insulin Aspart (Niacinamide) (Fiasp Flextouch) | $27.0M | 24,598 |
| 365 | Lisinopril/Hydrochlorothiazide (Lisinopril-Hydrochlorothiazide) | $26.8M | 2,304,445 |
| 366 | Dofetilide (Dofetilide) | $26.7M | 98,814 |
| 367 | Plecanatide (Trulance) | $26.6M | 36,026 |
| 368 | Ursodiol (Ursodiol) | $26.6M | 123,719 |
| 369 | Glycerol Phenylbutyrate (Ravicti) | $26.6M | 268 |
| 370 | Doravirine (Pifeltro) | $26.4M | 14,437 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology